減重和肥胖管理市場：按治療方法、給藥途徑、性別、年齡層、最終用戶和地區分類

據估計，2026年減重和肥胖管理市場規模為1,797.9億美元，預計2033年將達到3,265.7億美元。預計2026年至2033年，該市場將以8.9%的複合年成長率成長。

全球減重和肥胖管理市場是一個快速成長的醫療保健領域，其成長動力主要來自不斷上升的肥胖率、日益增強的健康意識以及全球對肥胖相關併發症認知的不斷提高。該市場涵蓋一系列旨在促進減重和維持健康體重的產品和服務，例如營養補充劑、代餐食品、健身器材、體重管理設備、藥物干預和外科手術。

該市場的成長主要受文明病（如糖尿病、心血管疾病和METABOLIC INC.症候群）日益普遍的推動，這些疾病催生了對有效體重管理解決方案的迫切需求。此外，非侵入性治療方法、數位健康平台和個人化營養方案等技術的進步也促進了該市場的發展，這些技術能夠滿足不同消費者的偏好和醫療需求。該行業服務於包括成人、青少年和兒童在內的廣泛人群，並透過從醫院、診所到零售藥局和線上平台等多種分銷管道進行銷售。政府倡導健康生活方式的舉措、不斷成長的醫療保健支出以及人們對體重管理的日益認可（不再僅僅將其視為一種美容選擇，而是將其視為一種醫療必需品），都進一步推動了市場擴張，使其成為全球醫療保健生態系統的重要組成部分。

市場動態

全球減重和肥胖管理市場的主要驅動力是全球肥胖率的驚人成長。根據世界衛生組織（WHO）統計，自1975年以來，肥胖症患者人數增加了兩倍，這使得各年齡層對有效的體重管理解決方案的需求顯著增加。人們對肥胖相關健康併發症（包括第2型糖尿病、心血管疾病、睡眠呼吸中止症和某些癌症）的認知不斷提高，促使人們尋求專業的體重管理干預，從而擴大了市場消費群。微創手術技術的創新、先進配方的研發以及包括行動應用程式和穿戴式裝置在內的數位健康技術的整合，顯著提高了治療效果和患者依從性，推動了市場成長。然而，該市場也面臨著許多限制因素，例如手術干預和高階體重管理計畫的高成本，這限制了低收入群體獲得治療的機會，並阻礙了其廣泛應用。此外，嚴格的減重藥物和醫療設備法規，以及某些干預措施可能存在的副作用和安全隱患，也進一步阻礙了市場擴張。此外，某些地區對肥胖和體重管理治療的文化偏見阻礙了市場滲透。儘管存在這些挑戰，新興經濟體仍蘊藏著巨大的機遇，因為可支配收入的成長、都市化的加速以及飲食習慣的改變正在催生新的客戶群。預防醫學的興起、遠端醫療的日益普及以及根據個人基因譜和生活方式因素量身定做的個人化營養和健身計劃的開發，為那些希望利用不斷變化的消費者偏好和醫療保健服務模式的市場相關人員提供了巨大的成長機會。

本研究的關鍵特徵

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數，介紹了全球減重和肥胖管理市場的主要公司概況：公司亮點、產品系列、主要亮點、財務表現和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 全球減重和肥胖管理市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以利用分析全球減重和肥胖管理市場中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 促進因素
• 抑制因子
• 機會
• 影響分析
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球減重與肥胖管理市場：依治療方法，2021-2033年

• 營養補充品
• 外科治療
• 微創或非手術治療

第5章 全球減重及肥胖管理市場：依給藥途徑分類，2021-2033年

• 口服
• 腸外
• 其他（經皮）

第6章 全球減重與肥胖管理市場：依性別分類，2021-2033年

• 男性
• 女士

第7章 全球減重及肥胖管理市場：依年齡層別分類，2021-2033年

• 成人
• 老年人
• 兒童

第8章 全球減重和肥胖管理市場：按最終用戶分類，2021-2033年

• 醫院和診所
• 門診手術中心（ASC）
• 居家醫療
• 肥胖治療中心或健身中心
• 其他

第9章 全球減重及肥胖管理市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第10章 競爭格局

• Novo Nordisk
• GlaxoSmithKline
• AstraZeneca
• Pfizer
• Merck & Co.
• Sanofi
• Amgen
• Eli Lilly and Company
• Johnson & Johnson
• Herbalife Nutrition Ltd
• GNC Holdings
• Amway
• Nestle Health Science
• Iovate Health Sciences
• Weight Watchers（WW International）
• SlimFast（Glanbia Performance Nutrition）
• Life Extension
• NutraScience Labs
• Other Players

第11章 分析師建議

• 機會分析
• 分析師意見
• 一致的機會地圖

第12章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Weight Loss And Obesity Management Market is estimated to be valued at USD 179.79 Bn in 2026 and is expected to reach USD 326.57 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.

The global weight loss and obesity management market represents a rapidly expanding healthcare sector driven by escalating obesity rates, increasing health consciousness, and growing awareness of obesity-related comorbidities worldwide. This market encompasses a comprehensive range of products and services including dietary supplements, meal replacements, fitness equipment, weight management devices, pharmaceutical interventions, and surgical procedures designed to facilitate weight reduction and maintain healthy body weight.

The market's growth trajectory is significantly influenced by rising prevalence of lifestyle-related diseases such as diabetes, cardiovascular disorders, and metabolic syndrome, which have created urgent demand for effective weight management solutions. Additionally, the market benefits from technological advancements in non-invasive treatment options, digital health platforms, and personalized nutrition approaches that cater to diverse consumer preferences and medical requirements. The industry serves various demographics including adults, adolescents, and pediatric populations through multiple distribution channels ranging from hospitals and clinics to retail pharmacies and online platforms. Government initiatives promoting healthy lifestyles, increasing healthcare expenditure, and growing acceptance of weight management as a medical necessity rather than cosmetic preference further propel market expansion, making it a critical component of the global healthcare ecosystem.

Market Dynamics

The global weight loss and obesity management market is primarily driven by the alarming increase in obesity rates globally, with the World Health Organization reporting that obesity has tripled since 1975, creating substantial demand for effective weight management solutions across all age groups. Rising awareness about obesity-related health complications including type 2 diabetes, cardiovascular diseases, sleep apnea, and certain cancers is compelling individuals to seek professional weight management interventions, thereby expanding the market's consumer base. Technological innovations in minimally invasive surgical procedures, development of advanced pharmaceutical formulations, and integration of digital health technologies including mobile applications and wearable devices are significantly enhancing treatment efficacy and patient compliance, driving market growth. However, the market faces considerable restraints including high costs associated with surgical interventions and premium weight management programs, which limit accessibility for lower-income populations and create barriers to widespread adoption. Stringent regulatory frameworks governing weight loss medications and medical devices, coupled with potential side effects and safety concerns associated with certain interventions, pose additional challenges to market expansion. Cultural stigma surrounding obesity and weight management treatments in certain regions also impedes market penetration. Despite these challenges, the market presents substantial opportunities through emerging economies where rising disposable incomes, urbanization, and changing dietary patterns are creating new customer segments. The growing trend toward preventive healthcare, increasing acceptance of telemedicine, and development of personalized nutrition and fitness programs tailored to individual genetic profiles and lifestyle factors offer significant growth potential for market players seeking to capitalize on evolving consumer preferences and healthcare delivery models.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global weight loss and obesity management market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novo Nordisk, GlaxoSmithKline, AstraZeneca, Pfizer, Merck & Co., Sanofi, Amgen, Eli Lilly and Company, Johnson & Johnson, Herbalife Nutrition Ltd, GNC Holdings, Amway, Nestle Health Science, Iovate Health Sciences, Weight Watchers (WW International), SlimFast (Glanbia Performance Nutrition), Life Extension, and NutraScience Labs.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global weight loss and obesity management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global weight loss and obesity management market

Market Segmentation

• Type of Treatment Insights (Revenue, USD Bn, 2021 - 2033)
• Drugs
  • Prescription Drugs
  • Over-the-Counter (OTC) Drugs
• Dietary Supplements
  • Nutraceuticals
  • Herbal or Botanical Supplements
  • Protein and Fiber Supplements
  • Vitamin or Mineral Formulations (Weight-Loss Focused)
  • Appetite suppressants
  • Others (Metabolism enhancers, etc.)
• Surgery Therapies
  • Bariatric Surgeries
    • Sleeve Gastrectomy
    • Biliopancreatic Diversion (BPD)
    • Others (Duodenal Switch, etc.)
  • Minimally Invasive or Non-Surgical Procedures
    • Intragastric Balloon Systems
    • Others (Endoscopic Sleeve Gastroplasty, etc.)
• Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
• Oral
• Parenteral
• Others (Transdermal)
• Gender Insights (Revenue, USD Bn, 2021 - 2033)
• Male
• Female
• Age Group Insights (Revenue, USD Bn, 2021 - 2033)
• Adult
• Geriatric
• Pediatric
• End User Insights (Revenue, USD Bn, 2021 - 2033)
• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)
• Homecare Settings
• Obesity Treatment Centers or Fitness Centers
• Others
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Novo Nordisk
• GlaxoSmithKline
• AstraZeneca
• Pfizer
• Merck & Co.
• Sanofi
• Amgen
• Eli Lilly and Company
• Johnson & Johnson
• Herbalife Nutrition Ltd
• GNC Holdings
• Amway
• Nestle Health Science
• Iovate Health Sciences
• Weight Watchers (WW International)
• SlimFast (Glanbia Performance Nutrition)
• Life Extension
• NutraScience Labs
• Other Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Weight Loss and Obesity Management Market, By Type of Treatment
  • Global Weight Loss and Obesity Management Market, By Route of Administration
  • Global Weight Loss and Obesity Management Market, By Gender
  • Global Weight Loss and Obesity Management Market, By Age Group
  • Global Weight Loss and Obesity Management Market, By End User
  • Global Weight Loss and Obesity Management Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Weight Loss and Obesity Management Market, By Type of Treatment, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
    • Drugs
      • Prescription Drugs
      • Over-the-Counter (OTC) Drugs
    • Dietary Supplements
      • Nutraceuticals
      • Herbal or Botanical Supplements
      • Protein and Fiber Supplements
      • Vitamin or Mineral Formulations (Weight-Loss Focused)
      • Appetite suppressants
      • Others (Metabolism enhancers, etc.)
    • Surgery Therapies
      • Bariatric Surgeries
      • Sleeve Gastrectomy
      • Biliopancreatic Diversion (BPD)
      • Others (Duodenal Switch, etc.)
    • Minimally Invasive or Non-Surgical Procedures
      • Intragastric Balloon Systems
      • Others (Endoscopic Sleeve Gastroplasty, etc.)

5. Global Weight Loss and Obesity Management Market, By Route of Administration, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others (Transdermal)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Weight Loss and Obesity Management Market, By Gender, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Male
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Female
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Weight Loss and Obesity Management Market, By Age Group, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Weight Loss and Obesity Management Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Ambulatory Surgical Centers (ASCs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Homecare Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Obesity Treatment Centers or Fitness Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Weight Loss and Obesity Management Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Novo Nordisk
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Amgen
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Herbalife Nutrition Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GNC Holdings
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Amway
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nestle Health Science
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Iovate Health Sciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Weight Watchers (WW International)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SlimFast (Glanbia Performance Nutrition)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Life Extension
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• NutraScience Labs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Other Players
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us